Eli Lilly and Company Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial
Licensed prescribers MDs, DOs, NPs, PAs in most states already have the authority to prescribe semaglutide, tirzepatide, oral Wegovy, and Foundayo for appropriate indications
Whilst cellulite is not listed as a side effect of Ozempic in clinical trials or product information, the weight loss associated with this GLP-1 receptor agonist can lead to changes in skin texture and appearance
An authorized agent may submit a request where permitted by law, subject to verification
IMBMS is India's bestseller of Skin whitening products
However, not all studies show identical benefits, and effectiveness may depend on the formulation used